Literature DB >> 20712823

Dopamine release in ventral striatum of pathological gamblers losing money.

Jakob Linnet1, E Peterson, D J Doudet, A Gjedde, A Møller.   

Abstract

OBJECTIVE: To investigate dopaminergic neurotransmission in relation to monetary reward and punishment in pathological gambling. Pathological gamblers (PG) often continue gambling despite losses, known as 'chasing one's losses'. We therefore hypothesized that losing money would be associated with increased dopamine release in the ventral striatum of PG compared with healthy controls (HC).
METHOD: We used Positron Emission Tomography (PET) with [(11)C]raclopride to measure dopamine release in the ventral striatum of 16 PG and 15 HC playing the Iowa Gambling Task (IGT).
RESULTS: PG who lost money had significantly increased dopamine release in the left ventral striatum compared with HC. PG and HC who won money did not differ in dopamine release.
CONCLUSION: Our findings suggest a dopaminergic basis of monetary losses in pathological gambling, which might explain loss-chasing behavior. The findings may have implications for the understanding of dopamine dysfunctions and impaired decision-making in pathological gambling and substance-related addictions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712823     DOI: 10.1111/j.1600-0447.2010.01591.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  43 in total

1.  Serotonin 1B receptor imaging in pathological gambling.

Authors:  Marc N Potenza; Espen Walderhaug; Shannan Henry; Jean-Dominique Gallezot; Beata Planeta-Wilson; Jim Ropchan; Alexander Neumeister
Journal:  World J Biol Psychiatry       Date:  2011-09-22       Impact factor: 4.132

2.  Reduced cortical thickness in gambling disorder: a morphometric MRI study.

Authors:  Jon E Grant; Brian L Odlaug; Samuel R Chamberlain
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-27       Impact factor: 5.270

3.  Abnormalities of striatal morphology in gambling disorder and at-risk gambling.

Authors:  Jon E Grant; Masanori Isobe; Samuel R Chamberlain
Journal:  CNS Spectr       Date:  2019-12       Impact factor: 3.790

4.  In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO.

Authors:  I Boileau; D Payer; B Chugani; D S S Lobo; S Houle; A A Wilson; J Warsh; S J Kish; M Zack
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

5.  Individual differences in dopamine D2 receptor availability correlate with reward valuation.

Authors:  Linh C Dang; Gregory R Samanez-Larkin; Jaime J Castrellon; Scott F Perkins; Ronald L Cowan; David H Zald
Journal:  Cogn Affect Behav Neurosci       Date:  2018-08       Impact factor: 3.282

6.  Commentary on Boileau et al. (2013): Distinguishing D2/D3 dopaminergic contributions to addictions.

Authors:  Marc N Potenza; Arthur L Brody
Journal:  Addiction       Date:  2013-05       Impact factor: 6.526

Review 7.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

8.  Comments and controversies: Piecing together the neurobiology of decision-making.

Authors:  Lynn M Oswald; Gary S Wand
Journal:  Neuroimage       Date:  2015-08-15       Impact factor: 6.556

9.  Risk-taking and decision-making in youth: relationships to addiction vulnerability.

Authors:  Kornelia N Balogh; Linda C Mayes; Marc N Potenza
Journal:  J Behav Addict       Date:  2013-03-01       Impact factor: 6.756

Review 10.  Impact of Sleep and Circadian Rhythms on Addiction Vulnerability in Adolescents.

Authors:  Ryan W Logan; Brant P Hasler; Erika E Forbes; Peter L Franzen; Mary M Torregrossa; Yanhua H Huang; Daniel J Buysse; Duncan B Clark; Colleen A McClung
Journal:  Biol Psychiatry       Date:  2017-12-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.